DK0876367T3 - Trans apovincaminsyreesterderivater som lægemidler - Google Patents

Trans apovincaminsyreesterderivater som lægemidler

Info

Publication number
DK0876367T3
DK0876367T3 DK96942534T DK96942534T DK0876367T3 DK 0876367 T3 DK0876367 T3 DK 0876367T3 DK 96942534 T DK96942534 T DK 96942534T DK 96942534 T DK96942534 T DK 96942534T DK 0876367 T3 DK0876367 T3 DK 0876367T3
Authority
DK
Denmark
Prior art keywords
trans
drugs
acid ester
ester derivatives
apovincamic acid
Prior art date
Application number
DK96942534T
Other languages
English (en)
Inventor
Csaba Szantay
Istvan Moldvai
Andras Vedres
Maria Incze
Janos Kreidl
Laszlo Czibula
Jenone Kirjak Maria Farkas
Ida Deutschnejuhasz
Aniko Gere
Margit Pellioniszneparoczai
Erzsebet Lapis
Andras Szekeres
Maria Zajernebalazs
Adam Sarkadi
Ferenc Auth
Bela Kiss
Egon Karpati
Sandor Farkas
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK0876367T3 publication Critical patent/DK0876367T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96942534T 1995-12-22 1996-12-13 Trans apovincaminsyreesterderivater som lægemidler DK0876367T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9503736A HU214600B (hu) 1995-12-22 1995-12-22 Transz-apovinkaminsav-észter-származékok, az azokat tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
PCT/HU1996/000075 WO1997023481A1 (en) 1995-12-22 1996-12-13 Trans apovincaminic acid ester derivatives as drugs

Publications (1)

Publication Number Publication Date
DK0876367T3 true DK0876367T3 (da) 2002-12-30

Family

ID=10987512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942534T DK0876367T3 (da) 1995-12-22 1996-12-13 Trans apovincaminsyreesterderivater som lægemidler

Country Status (22)

Country Link
US (1) US6093720A (da)
EP (1) EP0876367B1 (da)
JP (1) JP2000502676A (da)
KR (1) KR19990076606A (da)
CN (1) CN1072670C (da)
AR (1) AR005182A1 (da)
AT (1) ATE223914T1 (da)
AU (1) AU1166997A (da)
CA (1) CA2238635A1 (da)
CZ (1) CZ290383B6 (da)
DE (1) DE69623656T2 (da)
DK (1) DK0876367T3 (da)
ES (1) ES2181926T3 (da)
HU (1) HU214600B (da)
IL (1) IL124097A (da)
PL (1) PL186626B1 (da)
PT (1) PT876367E (da)
RU (1) RU2161157C2 (da)
TW (1) TW366348B (da)
UA (1) UA61062C2 (da)
WO (1) WO1997023481A1 (da)
ZA (1) ZA9610646B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054536A1 (ja) * 2004-11-16 2006-05-26 Nippon Shinyaku Co., Ltd. 尿路結石症治療剤
JP2008017734A (ja) * 2006-07-11 2008-01-31 Memory Secret Inc 精神的機能を改善するための栄養補助及び栄養摂取食品用の口経投与組成物
CN102485723A (zh) * 2010-12-02 2012-06-06 江苏斯威森生物医药工程研究中心有限公司 一锅法半合成长春西汀及其水溶性盐制备
CN114920743B (zh) * 2022-05-09 2023-08-04 南京中医药大学 一种吲哚生物碱及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531108A1 (de) * 1975-07-11 1977-02-03 Synthelabo Vincaminderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
HU186891B (en) * 1981-06-12 1985-10-28 Richter Gedeon Vegyeszet Process for producing esters of apovincaminic acid
IT1142026B (it) * 1981-07-21 1986-10-08 Ausonia Farma Srl Nuovo composto ad attivita' eumetabolica cerebrale
HU187733B (en) * 1982-06-30 1986-02-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing apovincaminic acid derivatives
JPS60248688A (ja) * 1984-05-24 1985-12-09 Sanwa Kagaku Kenkyusho:Kk 新規のアポビンカミン酸エステルおよびその酸付加塩並びにその製造方法

Also Published As

Publication number Publication date
CZ196298A3 (cs) 1998-10-14
AR005182A1 (es) 1999-04-14
PL328170A1 (en) 1999-01-18
UA61062C2 (en) 2003-11-17
CA2238635A1 (en) 1997-07-03
ES2181926T3 (es) 2003-03-01
CN1205701A (zh) 1999-01-20
AU1166997A (en) 1997-07-17
IL124097A (en) 2001-12-23
EP0876367A1 (en) 1998-11-11
US6093720A (en) 2000-07-25
ATE223914T1 (de) 2002-09-15
HU9503736D0 (en) 1996-02-28
CZ290383B6 (cs) 2002-07-17
KR19990076606A (ko) 1999-10-15
WO1997023481A1 (en) 1997-07-03
TW366348B (en) 1999-08-11
DE69623656D1 (en) 2002-10-17
RU2161157C2 (ru) 2000-12-27
JP2000502676A (ja) 2000-03-07
ZA9610646B (en) 1997-06-24
DE69623656T2 (de) 2003-05-22
PT876367E (pt) 2003-01-31
HUT76555A (en) 1997-09-29
CN1072670C (zh) 2001-10-10
EP0876367B1 (en) 2002-09-11
PL186626B1 (pl) 2004-02-27
HU214600B (hu) 1998-04-28

Similar Documents

Publication Publication Date Title
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DK0823895T3 (da) Fedtsyreestere som bioaktive forbindelser
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
FI954404L (fi) Fenoksifenyylietikkahappojohdannaiset
FI950910A7 (fi) Rasvahappojohdannaiset
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
NO981008D0 (no) Farmasöytisk formulering
FI945688A7 (fi) Etikkahappojohdannaisia
FI922953A7 (fi) 7-azaisoindolinylkinolon- och naftyridonkarboxylsyraderivat
ATE255117T1 (de) Aminophosphonsäure-derivate als arzneimittel
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
FI950909L (fi) Rasvahappojohdannaisia
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
BR9610214A (pt) Compostos farmacéuticos
FI942976A7 (fi) 5-amino-8-metyyli-7-pyrrolidinyylikinoliini-3-karboksyylihappojohdannaiset
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
FI973280A7 (fi) Farmaseuttinen koostumus
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
DE69616554D1 (de) Sialinsäure-derivate
FI941064A7 (fi) Asyylioksiheksaanihappojohdannaiset
FI940040A7 (fi) Nonatetraeenihappojohdannainen
NO965448L (no) Farmasöytiske forbindelser
AU1166997A (en) Trans apovincaminic acid ester derivatives as drugs
BR9605777A (pt) Composição farmacêutica